Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against <i>Acinetobacter </i>spp

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against <i>Acinetobacter </i>spp

Treatment of infections caused by<i> Acinetobacter </i>spp<i>., </i>particularly <i>A. baumannii</i>, is a major clinical problem due to its high rates of antibiotic resistance. New strategies must be developed; therefore, restoration of β-lactam efficacy through...

Full description

Bibliographic Details
Main Authors:	Cristina Lasarte-Monterrubio, Juan C. Vázquez-Ucha, Maria Maneiro, Jorge Arca-Suárez, Isaac Alonso, Paula Guijarro-Sánchez, John D. Buynak, Germán Bou, Concepción González-Bello, Alejandro Beceiro
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Antibiotics
Subjects:	<i>Acinetobacter</i> spp. <i>Acinetobacter baumannii</i> β-lactam antibiotic resistance β-lactamase inhibitors LN-1-255 imipenem
Online Access:	https://www.mdpi.com/2079-6382/10/2/210

Similar Items

Insights into the Periplasmic Proteins of <i>Acinetobacter baumannii</i> AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach
by: Daniela Scribano, et al.
Published: (2019-07-01)

Prevalence of antibiotic-resistant <i>Acinetobacter baumannii</i> in a 1000-bed tertiary care hospital in Tehran, Iran
by: Rahbar Mohammad, et al.
Published: (2010-04-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Determination of imipenem efflux-mediated resistance in Acinetobacter spp., using an efflux pump inhibitor
by: Ghazale Amiri, et al.
Published: (2019-11-01)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021-05-01)

Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii
by: Wang L, et al.
Published: (2021-09-01)

Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii
by: Karyne Rangel Carvalho, et al.
Published: (2011-06-01)

Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test
by: MA Boroumand, et al.
Published: (2009-06-01)

Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test
by: MA Boroumand, et al.
Published: (2009-06-01)

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii
by: Zhang Y, et al.
Published: (2018-03-01)

Mortality rate in patients with nosocomial Acinetobacter meningitis from a Brazilian hospital
by: Felipe Francisco Tuon, et al.

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
by: Chun-Hsiang Chiu, et al.
Published: (2020-01-01)

Molecular detection of AdeABC efflux pump genes in clinical isolates of Acinetobacter baumannii and their contribution in imipenem resistance
by: Ali Reza JaponiNejad, et al.
Published: (2014-11-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of <i>Acinetobacter baumannii</i>
by: Corneliu Ovidiu Vrancianu, et al.
Published: (2020-06-01)

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
by: Adam B. Shapiro, et al.
Published: (2021-07-01)

Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant <i>Acinetobacter baumannii</i> from Austria
by: Andrea J. Grisold, et al.
Published: (2021-02-01)

Long-Term Surveillance of Antibiotic Prescriptions and the Prevalence of Antimicrobial Resistance in Non-Fermenting Gram-Negative Bacilli
by: Chia-Huei Chou, et al.
Published: (2020-03-01)

Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon
by: D. Hammoudi, et al.
Published: (2015-07-01)

Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an Icu of a Tertiary Care Hospital
by: Sonika Agarwal, et al.
Published: (2017-01-01)

Hospital acquired antibiotic-resistant acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran
by: Parviz Vahdani, et al.
Published: (2011-01-01)

The Mutation of Conservative Asp268 Residue in the Peptidoglycan-Associated Domain of the OmpA Protein Affects Multiple <i>Acinetobacter baumannii</i> Virulence Characteristics
by: Jūratė Skerniškytė, et al.
Published: (2019-05-01)

Molecular Characterization and Genetic Diversity of Haplogroup E Human Lice in Guinea, West Africa
by: Alissa Hammoud, et al.
Published: (2021-01-01)

Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical <i>Enterobacter roggenkampii</i> Isolate
by: Suruchi Nepal, et al.
Published: (2021-04-01)

Competence for Natural Transformation Is Common among Clinical Strains of Resistant <i>Acinetobacter</i> spp.
by: Sara Domingues, et al.
Published: (2019-01-01)

An Application of Imipenem Discs or <i>P. aeruginosa</i> ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria
by: Tomasz Bogiel, et al.
Published: (2021-07-01)

Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Rogério Coutinho das Neves, et al.
Published: (2019-04-01)

Indole Degradation in a Model System and in Poultry Manure by <i>Acinetobacter</i> spp.
by: Tujuba Ayele Tesso, et al.
Published: (2019-04-01)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)

Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against <i>Acinetobacter baumannii</i>
by: Min Ji Hong, et al.
Published: (2021-05-01)

GENE EXPRESSION of blaOXA-51-like and blaOXA-23 in RESPONSE to β-Lactam ANTIBIOTIC IN CLINICALLY ISOLATED ACINETOBACTER BAUMANNII AND ACINETOBACTER LOWFFII FROM URINE SAMPLES
by: H. H. Al-Haideri
Published: (2019-08-01)

Studying the Relationship between the Ability of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Clinical and Environmental Isolates in Tehran, 2015
by: Faegheh Teymori, et al.
Published: (2017-07-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)

<i>Pimenta</i> Oil as A Potential Treatment for <i>Acinetobacter Baumannii</i> Wound Infection: In Vitro and In Vivo Bioassays in Relation to Its Chemical Composition
by: Maha M. Ismail, et al.
Published: (2020-10-01)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
by: Francisco Montiel-Riquelme, et al.
Published: (2020-10-01)

Shifting Gears: The Future of Polymyxin Antibiotics
by: Justin R. Lenhard, et al.
Published: (2019-04-01)

Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular <i>Acinetobacter baumannii</i>
by: Nuria Crua Asensio, et al.
Published: (2021-02-01)

Sequential Hypertonic-Hypotonic Treatment Enhances Efficacy of Antibiotic against <i>Acinetobacter baumannii</i> Biofilm Communities
by: Azeza Falghoush, et al.
Published: (2020-11-01)

Aminoglycoside 6′-<i>N</i>-acetyltransferase Type Ib [AAC(6′)-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions
by: Craig M. Reeves, et al.
Published: (2021-12-01)